The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry
First approved in 2019, Rinvoq is a JAK inhibitor approved for four indications across gastroenterology, dermatology and rheumatology
Over the next three years, BASF will continue to support Beyond Suncare by supplying the required raw materials free of charge and by providing technical expertise to further improve the formulation
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
This pre-packaged release is a ready-to-go solution with powerful, straightforward bioanalysis pipeline support
The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific
The investment will accelerate the overall Sarclisa development program
This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)
Subscribe To Our Newsletter & Stay Updated
